Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154669 · ClinicalTrials.gov registry record · Phase 3
Integrating Financial Coaching and Smoking Cessation Coaching
A Phase 3 study of Smoking, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 488
- Enrollment target
- 1
- Study location
NCT05154669: Recruiting Phase 3 study of Smoking, sponsored by NYU Langone Health.
NCT05154669 is a Phase 3 study of Smoking that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 488 participants, roughly in line with the 451-participant average among 123 other Smoking trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05154669, a Phase 3 study of Smoking, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 488 participants
- Enrollment target
- 1
- Study location
Study Summary
This study conduct a two-arm, parallel-group randomized controlled trial. The study will recruit and randomize 900 smokers (n=450 per arm) to either: (1) Control: Standard Smoking Cessation Counseling or (2) Intervention: Integrated Financial-Smoking Cessation Counseling.
Primary Outcome
The study will collect salivary cotinine from participants reporting 7-day abstinence from cigarettes on the 12-month survey. The study will use a saliva collection kit supplied by Salimetrics Inc. Participants will be classified as negative for salivary cotinine if their concentration is \<10ng/ml,
Conditions Studied
Interventions
- OTHER Financial counseling
- DRUG Nicotine Replacement Therapy Agent - Patches
- DRUG Nicotine Replacement Therapy Agent - Lozenges
- DRUG Nicotine Replacement Therapy Agent - Gum
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2022-12-08 |
| Est. Completion | 2027-12-01 |
| Phase | Phase 3 |
What NCT05154669 shows while recruiting
NCT05154669 is an interventional study that assigns participants to a tested intervention. The registered 488 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 451-participant average among 123 other Smoking trials with a reported enrollment target.
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 4 interventions - of which Financial counseling is the first listed.
NCT05154669 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05154669 about?
NCT05154669 is a clinical study titled "Integrating Financial Coaching and Smoking Cessation Coaching". This study conduct a two-arm, parallel-group randomized controlled trial. The study will recruit and randomize 900 smokers (n=450 per arm) to either: (1) Control: Standard Smoking Cessation Counseling or (2) Intervention: Integrated Financial-Smoking Cessation Counseling.
What is the current status of trial NCT05154669?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 488 participants. The study started on 2022-12-08. Estimated completion is 2027-12-01.
What conditions does trial NCT05154669 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT05154669?
The interventions under investigation include: Financial counseling (OTHER), Nicotine Replacement Therapy Agent - Patches (DRUG), Nicotine Replacement Therapy Agent - Lozenges (DRUG), Nicotine Replacement Therapy Agent - Gum (DRUG).
Who is sponsoring clinical trial NCT05154669?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05154669 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05154669's enrollment target sits among peer trials
488 34th of 123 higher than 90 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
COMPLETED · Phase 3
-
Tobacco Tactics Website for Operating Engineers
COMPLETED · Phase 3
-
Quitlink : A Leveraging Solution to Tobacco Counseling
COMPLETED · Phase 3
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06532877 · 488 participants · NA
Telephone Support in Advanced Gastrointestinal Cancer
- NCT06602479 · 488 participants · Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- NCT06794983 · 488 participants · NA
Calls and Coordination for Transitions of Care at Re-entry
- NCT06948435 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI